Adage Capital Partners’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,030,438
| Closed | -$12.6M | – | 857 |
|
|
2024
Q4 | $12.6M | Sell |
1,030,438
-325,438
| -24% | -$3.96M | 0.02% | 548 |
|
|
2024
Q3 | $22.7M | Sell |
1,355,876
-876,953
| -39% | -$14.7M | 0.04% | 423 |
|
|
2024
Q2 | $38.9M | Buy |
2,232,829
+1,282,829
| +135% | +$22.4M | 0.07% | 269 |
|
|
2024
Q1 | $16.2M | Buy |
+950,000
| New | +$16.2M | 0.03% | 505 |
|
|
2023
Q4 | – | Sell |
-1,150,000
| Closed | -$10.4M | – | 869 |
|
|
2023
Q3 | $10.4M | Hold |
1,150,000
| – | – | 0.02% | 553 |
|
|
2023
Q2 | $12.4M | Buy |
+1,150,000
| New | +$12.4M | 0.03% | 524 |
|
|
2021
Q3 | – | Sell |
-78,000
| Closed | -$2.01M | – | 1027 |
|
|
2021
Q2 | $2.01M | Sell |
78,000
-263,731
| -77% | -$6.79M | ﹤0.01% | 880 |
|
|
2021
Q1 | $14.2M | Buy |
+341,731
| New | +$14.2M | 0.03% | 569 |
|